To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy
Maximilian Strobl, Alexandra Martin, Jeffrey West, Jill Gallaher, Mark Robertson‐Tessi, Robert A. Gatenby, Robert M. Wenham, Philip K. Maini, Mehdi Damaghi, Alexander R.A. Anderson
Topics & Concepts
Ovarian cancerPARP inhibitorLeverage (statistics)DrugCombination therapyCancer therapyToxicityDrug resistanceComputer sciencePharmacologyMedicineCancerBiologyPoly ADP ribose polymerasePolymeraseMachine learningInternal medicineGeneMicrobiologyBiochemistryPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentAdvanced Electron Microscopy Techniques and Applications